-
Recently Written
- Instant Approval Payday Loans: Instant Solution for Urgent Requirements
- Pay Advance, Pay Day Advance Clientele
- What are My Payday Loan Rights?
- Bad Credit Payday Cash Advance: Though a Way to Get Fast Cash
- Instant Payday Cash Advance – Quick Access for Emergency
- Pay Day Advances: the Right Choice a Pay Advance
- Finding the Online Payday Advance Lender of Choice
- Easy Approval Payday Loans: No Hassle, Easy Approval
- Cash Advances: A Solution To Your Money Problems Or Not
- No Teletrack Payday Loan - Easy And Fast Way To Get Money In Emergencies
-
Categories
-
Archives
-
Blogroll
- Canadian Consumer Information
- Comptroller of Currency Administrator of National Banks
- Consumer Federation Of America
- Debt Advice
- Financial Consumer Agency of Canada
- Illinois Department of Financial and Professional Regulation
- Ohio Department of Service
- Responsible Lending
- Washington State Department Of Financial Institutions
 |  |  |  |  |  |
 |  |  |  |  |  |
Oct
30
Akorn to Advance Four Vaccines from the Serum Institute of India … - Genetic Engineering News (press release)- Topic: Pay Advance
Filed Under Pay Advance |
Under the agreement, Serum will manufacture the vaccines and grant Akorn exclusive marketing rights for the vaccines in the U. Akorn will pay Serum a marketing rights fee for each of the vaccine products that it decides to conduct clinical trials against. Akorn may decide not to fund the trials for any vaccine if it finds that the cost are prohibitive, but upon doing so, the exclusive right granted by Serum to Akorn for that vaccine will lapse. Net revenues will be split equally between Akorn and Serum, with Serum bearing all manufacturing costs and Akorn bearing all marketing costs. read more
[Tags]akorn, serum, vaccines, marketing, trials, u, pay advance[/Tags]